INFERGEN (interferon alfacon-1)

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company:

Approval Status:

Approved October 1997

Specific Treatments:

hepatitis C

Find Related Trials for The Following Conditions

General Information

A launch has taken place in the U.S. of Amgen's consensus interferon (interferon alfacon-1, INFERGEN) for the treatment of chronic hepatitis C virus infection.